The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling
Published version of a preprint
Abstract
Cancer-associated fibroblasts (CAF) are components of the tumor microenvironment whose contributions to malignant progression are not fully understood. Here, we show that the fibroblast activation protein (FAP) triggers induction of a CAF subset with an inflammatory phenotype directed by STAT3 activation and inflammation-associated expression signature marked by CCL2 upregulation. Enforcing FAP expression in normal fibroblasts was sufficient to endow them with an inflammatory phenotype similar to FAP(+)CAFs. We identified FAP as a persistent activator of fibroblastic STAT3 through a uPAR-dependent FAK-Src-JAK2 signaling pathway. In a murine liver tumor model, we found that FAP(+)CAFs were a major source of CCL2 and that fibroblastic STAT3-CCL2 signaling in this setting promoted tumor growth by enhancing recruitment of myeloid-derived suppressor cells (MDSC). The CCL2 receptor CCR2 was expressed on circulating MDSCs in tumor-bearing subjects and FAP(+)CAF-mediated tumor promotion and MDSC recruitment was abrogated in Ccr2-deficient mice. Clinically, we observed a positive correlation between stromal expression of FAP, p-STAT3, and CCL2 in human intrahepatic cholangiocarcinoma, a highly aggressive liver cancer with dense desmoplastic stroma, where elevated levels of stromal FAP predicted a poor survival outcome. Taken together, our results showed how FAP-STAT3-CCL2 signaling in CAFs was sufficient to program an inflammatory component of the tumor microenvironment, which may hav…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, CAFs secrete substantial amounts of growth factors, proinflammatory cytokines, and chemokines, particularly TGF-β, IL-6, and CC-chemokine ligand 2, which recruit immunosuppressive cells into the tumor stroma and lead to immune escape 20-22.”
From TBX3 shapes an immunosuppressive microenvironment and induces immunotherapy resistance (2025) · cites this paper as [21]
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0027 · Cited by 3,889
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Monocyte recruitment during infection and inflammation
Shi, C., & Pamer, E. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3070 · Cited by 3,015
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Feig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Rhim, A. D., Oberstein, P. E., Thomas, D. H., Mirek, E. T., Palermo, C. F., Sastra, S. A., Dekleva, E. N., Saunders, T., Becerra, C. P., Tattersall, I. W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.021 · Cited by 2,085
Cited by
Sorted by citations
Items 401–500 of 757
Immune niches orchestrated by intestinal mesenchymal stromal cells lining the crypt-villus
Sun, H., Tan, J., Chen, H., Wu, N., & Su, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1057932 · Cited by 18
Xie, R., Liu, L., Lu, X., He, C., & Li, G. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1067524 · Cited by 20
Benign lesions with 68Ga-FAPI uptake: a retrospective study
Shu, Q., Wang, Y., Deng, M., Chen, X., Liu, M., & Cai, L. (2023) · British Journal of Radiology · doi:10.1259/bjr.20220994 · Cited by 18
Wu, X., Lü, W., Zhang, W., Zhang, D., Mei, H., Zhang, M., Cui, Y., & Zhuo, Z. (2023) · Aging · doi:10.18632/aging.205205 · Cited by 21
An, Y.-Z., Cho, E. S., Ling, J., & Zhang, X. (2020) · BMC Cancer · doi:10.1186/s12885-020-07495-9 · Cited by 18
Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapy
Louis, C., Edeline, J., & Coulouarn, C. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1882998 · Cited by 18
HSP47 contributes to angiogenesis by induction of CCL2 in bladder cancer
Ma, W., Ou, T., Cui, X., Wu, K., Li, H., Li, Y., Peng, G., Xia, W., & Wu, S. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110044 · Cited by 18
Maurel, J., Sánchez-Cabús, S., Laquente, B., Gaba, L., Visa, L., Fabregat, J., Povés, I., Roselló, S., Díaz-Beveridge, R., Martín-Richard, M., et al. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3682-9 · Cited by 18
Sinkarevs, S., Štrumfs, B., Volkova, S., & Štrumfa, I. (2024) · Cells · doi:10.3390/cells13121057 · Cited by 17
Teixeira, A. F., Wang, Y., Iaria, J., ten Dijke, P., & Zhu, H. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70055 · Cited by 18
Wang, Q., Song, C. W., Zhao, C., Wei, X., De-li, L., Wu, Q., Li, J., & Yang, X. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145006 · Cited by 19
Self-citationChen, F., Fu, Y., Bai, G., Qiu, J., & Hua, K. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1634413 · Cited by 19
Yin, Z., Zhou, Y., Zhu, X., Goettl, R. A., Wang, C., Weiss, H. L., Evers, B. M., & Wang, Q. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218060 · Cited by 18
Chen, F., Bai, G., Liu, Q., He, G., Ding, Z., Liang, J., Wang, N., Qiu, J., & Hua, K. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02471-y · Cited by 17
New insights into fibrotic signaling in renal cell carcinoma
Chen, J., Yiu, W. H., Tang, P. M., & Tang, S. C. W. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1056964 · Cited by 18
Hu, Z., Jin, X., Hong, W., Sui, Q., Zhao, M., Huang, Y., Li, M., Wang, Q., Zhan, C., & Chen, Z. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00816-7 · Cited by 18
Zhang, R., Chen, S., Wang, Z., Ye, L., Yue, J., Li, M., Jiang, X., Peng, H., Guo, Z., Chen, L., et al. (2023) · Environmental Health Perspectives · doi:10.1289/ehp12259 · Cited by 17
Kou, L., Xie, X., Chen, X., Li, B., Li, J., & Li, Y. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03568-3 · Cited by 18
Self-citationJia, W., Liang, S., Jin, M., Li, S., Yuan, J., Zhang, J., Lin, W., Wang, Y., Nie, S., Ling, C., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155208 · Cited by 17
Zhou, X., Zhang, B., Hu, J., Shen, J., Chen, Z., Zhang, J., Wu, B., Zhou, E., Peng, S., Wong, T., et al. (2024) · The Innovation Medicine · doi:10.59717/j.xinn-med.2024.100052 · Cited by 17
Cutmore, L. C., Brown, N. F., Raj, D., Chauduri, S., Wang, P., Maher, J. F., Wang, Y., Lemoine, N. R., & Marshall, J. F. (2020) · Pancreatology · doi:10.1016/j.pan.2020.02.006 · Cited by 18
Li, F., Wu, X., Sun, Z., Cai, P. C., Wu, L., & Li, D. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s257529 · Cited by 17
Wang, J., Cheng, F. H. C., Tedrow, J., Chang, W., Zhang, C., & Mitra, A. K. (2020) · Cancers · doi:10.3390/cancers12113184 · Cited by 17
Nakamura, K., Kiniwa, Y., & Okuyama, R. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03612-8 · Cited by 18
Liu, L., Zhang, Y., Liu, H., Yang, J., Tian, Q., Chueakula, N., Ramasamy, S. K., Verma, N. K., Cheung, C., & Kusumbe, A. P. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-4744 · Cited by 16
Chen, Z., Feng, X., Pathak, J. L., Fu, Z., Chen, X., Zeng, L., Zheng, Y., Qiu, Q., Qiao, L., & Wu, L. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218410 · Cited by 16
Akter, Z., Salamat, N., Ali, M. Y., & Li, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1072739 · Cited by 17
Functional roles of FAP-α in metabolism, migration and invasion of human cancer cells
Mori, N., Jin, J., Krishnamachary, B., Mironchik, Y., Wildes, F. B., Vesuna, F., Barnett, J. D., & Bhujwalla, Z. M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1068405 · Cited by 16
Al-Bzour, N., Al-Bzour, A. N., Ababneh, O. E., Al-Jezawi, M. M., Saeed, A., & Saeed, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216505 · Cited by 17
Chen, J., Zhang, L., Zhu, Y., Zhao, D., Zhang, J., Zhu, Y., Pang, J., Xiao, Y., Wu, Q., Wang, Y., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01728-6 · Cited by 16
Li, Y., Liang, Y., Zhang, S., Wang, X., Zhu, Y.-N., Liu, J., Ren, H., Jiang, W., Wang, J., Zhang, Z., et al. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108537 · Cited by 18
Lin, H.-J., Liang, T., Chang, Y.-Y., Liu, D.-Z., Fan, J.-Y., Roffler, S. R., & Lin, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061202 · Cited by 16
Self-citationNiu, W., Wang, B., Zhang, Y., Wang, C., Cao, J., Li, J., He, Y., & Lei, P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1433679 · Cited by 15
Miao, Y., Deng, Y., Liu, J., Wang, J., Hu, B., Hao, S., Wang, H., Zhang, Z., Jin, Z., Zhang, Y., et al. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14024 · Cited by 16
Wang, Z., Zhang, M., Liu, L., Yan, Y., Qiu, J., Yu, Y., & Li, J. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110837 · Cited by 15
Targeting FAPα-positive lymph node metastatic tumor cells suppresses colorectal cancer metastasis
Fan, S., Qi, M., Qi, Q., Miao, Q., Deng, L., Pan, J., Qiu, S., He, J., Huang, M., Li, X., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.002 · Cited by 15
Zhang, Q., Wang, J., Zhang, J., Wang, Y., Wang, Y., & Liu, F. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.111016 · Cited by 15
Glabman, R. A., Olkowski, C. P., Minor, H. A., Bassel, L., Kedei, N., Choyke, P. L., & Sato, N. (2024) · Cancers · doi:10.3390/cancers16020449 · Cited by 15
Diagnostic yield of FAP-guided positron emission tomography in thyroid cancer: a systematic review
Rizzo, A., Albano, D., Dondi, F., Cioffi, M., Muoio, B., Annunziata, S., Racca, M., Bertagna, F., Piccardo, A., & Treglia, G. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1381863 · Cited by 15
Cancer-associated fibroblasts: heterogeneity and their role in the tumor immune response
Xiao, Y., Wang, Z., Gu, M., Wei, P., Wang, X., & Li, W. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01375-3 · Cited by 15
Genetic and microenvironmental evolution of colorectal liver metastases under chemotherapy
Shi, M., Yang, Y., Huang, N., Zeng, D., Mo, Z., Wang, J., Zhang, X., Liu, R., Wang, C., Rong, X., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101838 · Cited by 17
Role of CC-chemokine ligand 2 in gynecological cancer
Zhang, J., Liu, W., Xing, G.-Z., Li, X., Zheng, W., & Ma, Z. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02763-z · Cited by 15
Self-citationReprogramming the tumor microenvironment to improve the efficacy of cancer immunotherapies
Faraj, J. A., Al-Athari, A. J. H., Mohie, S. E. D., Kadhim, I. K., Jawad, N. M., Abbas, W. J., & Jalil, A. T. (2022) · Medical Oncology · doi:10.1007/s12032-022-01842-5 · Cited by 16
Lu, Y., Li, H., Zhao, P., Wang, X., Shao, W., Liu, Y., Tian, L., Zhong, R., Liu, H., & Cheng, Y. (2024) · Molecular Medicine · doi:10.1186/s10020-024-01051-y · Cited by 16
Feng, Y., Jiang, Y., Yang, L., Lu, D., Li, N., Zhang, Q., Yang, H., Qin, H., Zhang, J., Gou, X., et al. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108586 · Cited by 15
Microenvironmental Snail1-induced immunosuppression promotes melanoma growth
Arumí-Planas, M., Rodríguez‐Baena, F. J., Cabello-Torres, F., Gracià, F., López-Blau, C., Nieto, M. A., & Sánchez‐Laorden, B. L. (2023) · Oncogene · doi:10.1038/s41388-023-02793-5 · Cited by 15
Lian, W., Xiang, P., Ye, C., & Xiong, J. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673282799231211113347 · Cited by 14
Zou, Z., Luo, T., Wang, X., Wang, B., & Li, Q. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31278 · Cited by 15
The Role of FAPI PET Imaging in Pancreatic Cancer: A Meta-analysis Compared with 18F-FDG PET
Hu, X., Li, X., Wang, P., & Cai, J. (2024) · Academic Radiology · doi:10.1016/j.acra.2024.07.032 · Cited by 17
Corvigno, S., Fernebro, J., Karlsson, J. S., Mezheieusky, A., Martín-Bernabé, A., de la Fuente, L. M., Westbom-Fremer, S., Carlson, J. W., Klein, C., Kannisto, P., et al. (2025) · Gynecologic Oncology · doi:10.1016/j.ygyno.2025.01.010 · Cited by 14
Morisada, M. V., Chamberlin, M. M., & Allen, C. T. (2018) · Head & Neck · doi:10.1002/hed.25101 · Cited by 14
BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration
Dufrusine, B., Damiani, V., Capone, E., Pieragostino, D., Dainese, E., Marco, M. D., Reppucci, F., Turco, M. C., Rosati, A., Marzullo, L., et al. (2021) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30172 · Cited by 15
Li, Z., Liu, C., Li, C., Wang, F., Liu, J., Zheng, Z., Wu, J., & Zhang, B. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01172-0 · Cited by 14
Jin, J., Barnett, J. D., Krishnamachary, B., Mironchik, Y., Luo, C. K., Kobayashi, H., & Bhujwalla, Z. M. (2022) · Cancer Science · doi:10.1111/cas.15601 · Cited by 15
Cancer-associated fibroblasts: Just on the opposite side of antitumour immunity?
Guo, S., Yuan, J., Meng, X., Feng, X., Ma, D., Han, Y., & Li, K. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110601 · Cited by 14
Byrling, J., Sasor, A., Nilsson, J., Hilmersson, K. S., Andersson, R. E., & Andersson, B. (2020) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2019.1708449 · Cited by 14
Tsutsumi, C., Ohuchida, K., Yamada, Y., Shimada, Y., Imamura, M., Son, K., Mochida, Y., Katayama, N., Iwamoto, C., Torata, N., et al. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-02981-y · Cited by 15
Shi, X., Zhu, W., Zhang, J., Fan, C., & Zhang, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1620075 · Cited by 13
Minini, M., Avveduto, G., Becharef, S., Meunier--Thaens, M., Lekbaby, B., Pérez-Lanzón, M., Machado, A., Guilbert, T., Lesieur, J., Renault, G., et al. (2025) · Hepatology · doi:10.1097/hep.0000000000001545 · Cited by 13
Heterogeneity and plasticity of cancer-associated fibroblasts
Pramod, S., Lavon, H., Scherz‐Shouval, R., & Sherman, M. H. (2026) · Nature Cancer · doi:10.1038/s43018-026-01146-x · Cited by 14
Exploring the association of POSTN+ cancer-associated fibroblasts with triple-negative breast cancer
Lin, S., Zhou, M., Cheng, L., Shuai, Z., Zhao, M., Jie, R., Wan, Q., Peng, F., & Ding, S. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131560 · Cited by 13
Tokhanbigli, S., Haghi, M., Dua, K., & Oliver, B. G. G. (2024) · Cancer Drug Resistance · doi:10.20517/cdr.2024.55 · Cited by 14
Bai, H., Zhu, X., Gao, L., Feng, S., Li, H., Gu, X., Xu, J., Zong, C., Hou, X., Yang, X. F., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-024-07270-9 · Cited by 13
Self-citationBhat, A. S., Singh, N. A., Rymbai, E., Birendra, S., Saravanan, J., & Selvaraj, D. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01064-0 · Cited by 17
Fibroblast activation protein is dispensable in the anti-influenza immune response in mice
Tan, S., Chowdhury, S., Polak, N., Gorrell, M. D., & Weninger, W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171194 · Cited by 13
Zhou, L., YANG, K. Y., Dunaway, S., ABDEL‐MALEK, Z. A., Andl, T., Kadekaro, A. L., & Zhang, Y. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12657 · Cited by 13
Meng, Y., Zhang, H., Li, Q., Xing, P., Liu, F., Cao, K., Fang, X., Li, J., Yu, J., Feng, X., et al. (2021) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27648 · Cited by 12
Heterocellular crosstalk and architecture of the pancreatic tumour microenvironment
Arnold, F., Vecchio, A. D., Hussain, Z., & Sherman, M. H. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-025-00905-9 · Cited by 15
Manzéger, A., Garmaa, G., Mozes, M. M., Hansmann, G., & Kökény, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115520 · Cited by 12
Evidence of the Link between Stroma Remodeling and Prostate Cancer Prognosis
Vecchiotti, D., Clementi, L., Cornacchia, E., Nolfi, M. D. V., Verzella, D., Capece, D., Zazzeroni, F., & Angelucci, A. (2024) · Cancers · doi:10.3390/cancers16183215 · Cited by 12
Qi, L., Wang, J., Hou, S., Liu, S., Zhang, Q., Zhu, S., Liu, S., & Zhang, S. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189264 · Cited by 15
Zhou, C., Hu, X., Liu, Q., Wang, L., Zhou, Y., Jin, Y., Ma, Y., & Liu, Y. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c01131 · Cited by 12
Tanuma, S., Oyama, T., Okazawa, M., Yamazaki, H., Takao, K., Sugita, Y., Amano, S., Abe, T., & Sakagami, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073426 · Cited by 11
The cellular and molecular mediators of metastasis to the lung
Cucanic, O., Farnsworth, R. H., & Stacker, S. A. (2022) · Growth Factors · doi:10.1080/08977194.2022.2087520 · Cited by 13
FK866 inhibits colorectal cancer metastasis by reducing NAD+ levels in cancer-associated fibroblasts
Xie, H., Lei, Y., Mao, Y., Lan, J., Yang, J., Quan, H., & Zhang, T. (2022) · Genes & Genomics · doi:10.1007/s13258-022-01318-w · Cited by 11
Muilwijk, T., Baekelandt, L., Akand, M., Daelemans, S., Marien, K. M., Waumans, Y., van Dam, P., Kockx, M. M., den Broeck, T. V., Cleynenbreugel, B. V., et al. (2024) · European Urology Open Science · doi:10.1016/j.euros.2024.06.011 · Cited by 11
Lubuela, G., Bèaufrere, A., Albuquerque, M., Pignollet, C., Nicolle, R., Lesurtel, M., Bouattour, M., Cros, J. F., & Paradis, V. (2024) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-024-03922-5 · Cited by 11
Inflammation and Immunity in Liver Neoplasms: Implications for Future Therapeutic Strategies
Kim, J., & Seki, E. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0726 · Cited by 11
Corvigno, S., Burks, J. K., Hu, W., Zhong, Y., Jennings, N. B., Fleming, N. D., Westin, S. N., Fellman, B. M., Liu, J., & Sood, A. K. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03778-1 · Cited by 11
Zhou, L., Lin, X., Zhang, L., Chen, S., Chen, J., Zhou, Z., Tang, A., Ruan, J., Wang, X., & Chen, B. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109329 · Cited by 11
Cell-specific expression of the FAP gene is regulated by enhancer elements
Antonova, D. V., Gnatenko, D. A., Kotova, E. S., Pleshkan, V. V., Kuzmich, A. I., Didych, D. A., Sverdlov, E. D., & Алексеенко, И. В. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1111511 · Cited by 11
Up-Regulation of CX3CL1 via STAT3 Contributes to SMIR-Induced Chronic Postsurgical Pain
Shen, Y., Li, D., Li, B., Peng, X., Zhang, Y., Jiang, Y.-S., Xu, Y., Chen, H., & Xiong, Y.-C. (2018) · Neurochemical Research · doi:10.1007/s11064-017-2449-8 · Cited by 12
Self-citationLoss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice
Liu, J., Muturi, H. T., Khuder, S. S., Helal, R. A., Ghadieh, H. E., Ramakrishnan, S. K., Kaw, M., Lester, S. G., Al-Khudhair, A., Conran, P. B., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154215 · Cited by 11
A cell-based fluorescent assay for FAP inhibitor discovery
Zhang, B., Liu, F., Yang, M.-F., Xu, J., Wang, Z., Zhang, J., Wang, R., & Yang, X. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127253 · Cited by 11
Self-citationLiu, C. X., & Wong, C. C.-L. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2025.0889 · Cited by 10
The Immune Microenvironment in Liver Cancer: From Analysis to Targeting
Lan, J., Li, H., Xue, J., Duan, Y., Sun, J., & Niu, M. (2025) · Advanced Science · doi:10.1002/advs.202518487 · Cited by 10
Adusumalli, R., & Banala, R. R. (2025) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-025-00334-7 · Cited by 11
An Immune-privileged niche mediates immunotherapy resistance in esophageal carcinoma
Wan, L., Li, B., Ma, T., Wang, M., Xie, F., Ge, H., Xiao, Z., Chen, X., Meng, L., Zhang, L., et al. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-013959 · Cited by 10
Self-citationKumar, S., Arwind, D. A., Harish Kumar., B., Pandey, S., Nayak, R., Vithalkar, M. P., Kumar, N., & Pai, K. S. R. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102023 · Cited by 13
Chen, Y., Du, J., Meng, X., Wu, L., Zhang, Q., Han, X., Zhang, L., Wang, Q., & Hu, H. (2024) · Talanta · doi:10.1016/j.talanta.2024.126475 · Cited by 10
Kwantwi, L. B., & Tandoh, T. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03723-x · Cited by 11
The multi-faceted roles of cancer-associated fibroblasts in pancreatic cancer
Kwon, J. Y., Vera, R. E., & Fernández-Zapico, M. E. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111584 · Cited by 10
Liu, X., Wang, C., Mao, H., & Wei, J. (2025) · Oncology Reports · doi:10.3892/or.2025.8926 · Cited by 10
Sliker, B. H., & Campbell, P. M. (2021) · Vaccines · doi:10.3390/vaccines9060634 · Cited by 10
Li, Z., Zhang, X., Liu, C., & Ma, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.729941 · Cited by 10
Tumor microenvironment in non-melanoma skin cancer resistance to photodynamic therapy
Cerro, P. A., Mascaraque, M., Gallego-Rentero, M., Almenara‐Blasco, M., Morala, J. N., Santiago, J. L., González, S., Gracia‐Cazaña, T., Juarranz, Á., & Gilaberte, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.970279 · Cited by 10
Shi, T., Yao, L., Han, Y., Hao, P., & Lu, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215400 · Cited by 10
Avagliano, A., & Arcucci, A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220620124138 · Cited by 10
Tumor microenvironment mimicking 3D models unveil the multifaceted effects of SMAC mimetics
Pinto, C., Slavic-Obradovic, K., Fürweger, D., Thaler, B., Souabni, A., Carotta, S., Aichinger, M., Reiser, U., Impagnatiello, M. A., & Tirapu, I. (2023) · iScience · doi:10.1016/j.isci.2023.106381 · Cited by 9
Zhu, T., Wu, X., Liao, Y., Yan, Y., Yu, M., Wang, L., & Xia, Q. (2023) · Clinical Cancer Bulletin · doi:10.1007/s44272-023-00005-5 · Cited by 8
Metadata
- Authors
- Yang, X., Lin, Y., Shi, Y., Li, B., Liu, W., Yin, W., Dang, Y., Chu, Y., Fan, J., & He, R.
- Affiliations
- Shanghai Medical College of Fudan University (CN)
- Venue
- Cancer Research
- Published
- 2016-07-14
- Volume
- 76
- Issue
- 14
- Pages
- 4124-4135
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2400022769
- Cited by
- 748
- References
- 44
- Citations by year
- 2026: 66 · 2025: 101 · 2024: 107 · 2023: 115 · 2022: 91 · 2021: 95 · 2020: 67 · 2019: 47 · 2018: 31 · 2017: 25 · 2016: 3
- FWCI
- 19.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NSFC (813220437, 81471555, 81272389)
- National Key Sci-Tech Project (2012ZX10002011-002)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- fibroblast activation protein, cancer-associated fibroblasts, tumor microenvironment, STAT3 signaling, MCP-1, CCR2, myeloid-derived suppressor cells, uPAR, desmoplasia, intrahepatic cholangiocarcinoma, liver cancer, immunosuppression, tumor stroma
- MeSH terms
- Cancer-Associated Fibroblasts, Fibroblast Activation Protein Alpha, Animals, Cell Movement, Female, Immune Tolerance, Membrane Proteins, Mice, Inbred C57BL, Endopeptidases, Serine Endopeptidases, Signal Transduction, Gelatinases, Chemokine CCL2, STAT3 Transcription Factor, Mice, Focal Adhesion Protein-Tyrosine Kinases, Janus Kinase 2, Receptors, Urokinase Plasminogen Activator, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review